[Bora] Announcement of the Board's approval of the Q1 2026 consolidated financial report
📋 Article Processing Timeline
- 📰 Published: May 13, 2026 at 09:00
- 🔍 Collected: May 14, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 15, 2026 at 08:23 (24h 23m after Collected)
Bora Pharmaceuticals announced its Q1 2026 consolidated financial results approved by the Board. For the period from January 1 to March 31, 2026, the company reported cumulative operating revenue of TWD 4,001,231 thousand, gross profit of TWD 1,441,258 thousand, and operating income of TWD 407,236 thousand. Net income attributable to owners of the parent was TWD 25,838 thousand, with basic earnings per share (EPS) at TWD 0.21. Total assets stood at TWD 45,331,756 thousand. The net income includes a discontinued operations loss of TWD 14,449 thousand.